LIONTOWN LIMITED — Director's Dealing 2020

Apr 19, 2020

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Liontown Resources Limited ABN 39 118 153 825

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Craig R Williams
Date of last notice	29 November 2019

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	1) Registered Holder: Invia Custodian Pty Ltd Beneficial Holder: Orpheus Geoscience Pty Ltd as trustee for the Orpheus Geoscience Superannuation Fund. Craig Williams is a Director of Orpheus Geoscience Pty Ltd. 2) Oresome Pty Ltd as trustee for the Williams Family Trust. Craig Williams is a Director of Oresome Pty Ltd and a beneficiary of the Williams Family Trust.
Date of change	16 April 2020

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held prior to change	Indirect interest: 1) Orpheus Geoscience Superannuation Fund 21,429,080 fully paid ordinary shares. 2) Williams Family Trust 1,000,000 unlisted options with an exercise price of 3.5 cents and expiry date of 31 March 2021. 2,000,000 unlisted options with an exercise price of 2 cents and expiry date of 31 October 2022. 2,500,000 unlisted option with an exercise price of 3.5 cents and expiry date of 28 November 2023. 2,000,000 unlisted options with an exercise price of 15 cents and expiry date of 28 November 2022.
Class	Fully Paid Ordinary Shares
Number acquired	535,000
Number disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	$0.0939 per ordinary share
No. of securities held after change	Indirect interest: 1) Orpheus Geoscience Superannuation Fund 21,964,080 fully paid ordinary shares. 2) Williams Family Trust 1,000,000 unlisted options with an exercise price of 3.5 cents and expiry date of 31 March 2021. 2,000,000 unlisted options with an exercise price of 2 cents and expiry date of 31 October 2022. 2,500,000 unlisted option with an exercise price of 3.5 cents and expiry date of 28 November 2023. 2,000,000 unlisted options with an exercise price of 15 cents and expiry date of 28 November 2022.
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	On market purchase

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 2

Appendix 3Y Change of Director’s Interest Notice

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	N/A
Interest after change

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 3